Healthcare provider profile · identity verified

James Obrien, MD

Family Practice · BAKERSFIELD, CA · NPI 1750494175

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	798	229
Lisinopril	Lisinopril	424	123
Losartan Potassium	Losartan Potassium	365	118
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	324	66
Rosuvastatin Calcium	Rosuvastatin Calcium	305	97
Amlodipine Besylate	Amlodipine Besylate	288	92
Oxycodone Hcl	Oxycodone Hcl	257	69
Metformin Hcl	Metformin Hcl	235	69
Levothyroxine Sodium	Levothyroxine Sodium	232	65
Gabapentin	Gabapentin	201	57
Pradaxa	Dabigatran Etexilate Mesylate	201	62
Tamsulosin Hcl	Tamsulosin Hcl	195	59
Trazodone Hcl	Trazodone Hcl	193	62
Metoprolol Tartrate	Metoprolol Tartrate	180	54
Albuterol Sulfate Hfa	Albuterol Sulfate	160	70
Pantoprazole Sodium	Pantoprazole Sodium	151	57
Hydrochlorothiazide	Hydrochlorothiazide	147	48
Simvastatin	Simvastatin	137	38
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	133	42
Potassium Chloride	Potassium Chloride	132	48
Glipizide	Glipizide	120	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	120	40
Fluoxetine Hcl	Fluoxetine Hcl	100	30
Furosemide	Furosemide	96	36
Metoprolol Succinate	Metoprolol Succinate	96	35
Allopurinol	Allopurinol	94	29
Carvedilol	Carvedilol	90	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	84	15
Sertraline Hcl	Sertraline Hcl	82	24
Buspirone Hcl	Buspirone Hcl	81	29
Metformin Hcl Er	Metformin Hcl	80	26
Omeprazole	Omeprazole	79	27
Triamcinolone Acetonide	Triamcinolone Acetonide	77	40
Alvesco	Ciclesonide	70	27
Citalopram Hbr	Citalopram Hydrobromide	69	20
Alendronate Sodium	Alendronate Sodium	65	21
Spironolactone	Spironolactone	65	22
Atenolol	Atenolol	64	20
Clopidogrel	Clopidogrel Bisulfate	60	16
Humulin N	Insulin Nph Human Isophane	57	18
Famotidine	Famotidine	56	17
Meloxicam	Meloxicam	55	21
Jardiance	Empagliflozin	54	15
Ondansetron Odt	Ondansetron	53	21
Terazosin Hcl	Terazosin Hcl	52	15
Spiriva Respimat	Tiotropium Bromide	49	22
Prednisone	Prednisone	48	32
Lorazepam	Lorazepam	47	17
Nystatin	Nystatin	47	17
Duloxetine Hcl	Duloxetine Hcl	46	12
Fluticasone Propionate	Fluticasone Propionate	46	14
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Cephalexin	Cephalexin	44	26
Bupropion Xl	Bupropion Hcl	42	16
Mirtazapine	Mirtazapine	40	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	38
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	39
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	39	11
Ozempic	Semaglutide	38	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	38	34
Wixela Inhub	Fluticasone Propion/Salmeterol	38	19
Bupropion Hcl Sr	Bupropion Hcl	37	13
Hydromorphone Hcl	Hydromorphone Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Pregabalin	Pregabalin	34	11
Methylphenidate Hcl	Methylphenidate Hcl	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Ibuprofen	Ibuprofen	31	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	31	11
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	12
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Estradiol	Estradiol	29	16
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	28	28
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Fluconazole	Fluconazole	28	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Torsemide	Torsemide	26	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	15
Finasteride	Finasteride	25	suppressed
Trospium Chloride	Trospium Chloride	25	suppressed
Humulin R	Insulin Regular, Human	24	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Baclofen	Baclofen	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	12
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Eliquis	Apixaban	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Naloxone Hcl	Naloxone Hcl	19	11
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Amoxicillin	Amoxicillin	17	12
Diazepam	Diazepam	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Fluoridex	Fluoride (Sodium)	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Epinephrine	Epinephrine	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	12
Fentanyl	Fentanyl	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Topiramate	Topiramate	12	suppressed
Yuvafem	Estradiol	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error